SMTL ID : 3kme.2 (1 other biounit)

Crystal structure of catalytic domain of TACE with phenyl-pyrrolidinyl-tartrate inhibitor

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 1.85 Å

Oligo State

monomer

Ligands

1 x ZN: ZINC ION(Non-covalent)

ZN.1: 4 residues within 4Å: Chain A: H.191, H.195, H.201 Ligands: Z59.2 3 PLIP interactions: 3 interactions with chain A Metal complexes: A:H.191, A:H.195, A:H.201

1 x Z59: (2R,3R)-2,3-dihydroxy-4-oxo-4-[(2R)-2-phenylpyrrolidin-1-yl]-N-(thiophen-2-ylmethyl)butanamide(Non-covalent)

Z59.2: 17 residues within 4Å: Chain A: T.133, L.134, G.135, L.136, L.187, V.188, H.191, E.192, H.195, H.201, V.220, Y.222, P.223, I.224, A.225, V.226 Ligands: ZN.1 6 PLIP interactions: 6 interactions with chain A Hydrophobic interactions: A:H.191, A:V.226 Hydrogen bonds: A:L.134, A:G.135 pi-Stacking: A:H.191, A:H.201

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Rosner, K.E. et al., The discovery of novel tartrate-based TNF-alpha converting enzyme (TACE) inhibitors. Bioorg.Med.Chem.Lett. (2009)

Release Date

2009-12-22

Peptides

TNF-alpha-converting enzyme: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
B

TNF-alpha-converting enzyme

Related Entries With Identical Sequence